DOI 10.1080/02699052.2026.2739953
Association of dexmedetomidine use with stroke-heart syndrome in critically ill patients with ischemic stroke: a MIMIC-IV study.
Аннотация
BACKGROUND
Stroke-heart syndrome (SHS) is associated with poor outcomes after ischemic stroke (IS), but the relationship between dexmedetomidine (DEX) use and SHS remains unclear.
OBJECTIVE
To evaluate the association between DEX use and SHS in critically ill patients with IS.
METHODS
This retrospective cohort study used MIMIC-IV v2.2. Patients with IS receiving mechanical ventilation were included. DEX exposure was defined as use within 72 hours after ICU admission. Multivariate logistic regression, inverse probability of treatment weighting (IPTW), restricted cubic splines, and subgroup analyses were performed.
RESULTS
Among 953 patients, 146 (15.3%) received DEX. In the fully adjusted model, DEX use was associated with lower odds of SHS (OR = 0.611, 95% CI: 0.398-0.929, p = 0.023). The associations of cumulative DEX dose (p-nonlinearity = 0.018) and treatment duration (p-anonlinearity = 0.011) with SHS were nonlinear. Antiplatelet therapy significantly modified the DEX-SHS association (p-interaction = 0.042).
CONCLUSION
DEX use was associated with lower odds of SHS in critically ill patients with IS. Antiplatelet therapy may modify this association. Prospective studies are needed to confirm these findings.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.